6-7571554-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004415.4(DSP):c.1873C>T(p.Gln625*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000137 in 1,461,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004415.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSP | NM_004415.4 | c.1873C>T | p.Gln625* | stop_gained | Exon 14 of 24 | ENST00000379802.8 | NP_004406.2 | |
DSP | NM_001319034.2 | c.1873C>T | p.Gln625* | stop_gained | Exon 14 of 24 | NP_001305963.1 | ||
DSP | NM_001008844.3 | c.1873C>T | p.Gln625* | stop_gained | Exon 14 of 24 | NP_001008844.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSP | ENST00000379802.8 | c.1873C>T | p.Gln625* | stop_gained | Exon 14 of 24 | 1 | NM_004415.4 | ENSP00000369129.3 | ||
DSP | ENST00000418664.2 | c.1873C>T | p.Gln625* | stop_gained | Exon 14 of 24 | 1 | ENSP00000396591.2 | |||
DSP | ENST00000710359.1 | c.1873C>T | p.Gln625* | stop_gained | Exon 14 of 24 | ENSP00000518230.1 | ||||
DSP | ENST00000684395.1 | n.257C>T | non_coding_transcript_exon_variant | Exon 2 of 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461882Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727238
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 8;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln625*) in the DSP gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in DSP are known to be pathogenic (PMID: 20716751, 24503780, 25227139). This variant has been observed in an individual affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 21606390). ClinVar contains an entry for this variant (Variation ID: 228253). This variant is not present in population databases (ExAC no frequency). -
Arrhythmogenic right ventricular cardiomyopathy Pathogenic:1
The p.Gln625X variant in DSP has been reported in 1 individual with ARVC (Quarta 2011) and was absent from large population studies. This nonsense variant leads to a premature termination codon at position 625 which is predicted to lead to a truncated or absent protein. Frameshift and nonsense variants in DSP have been reported in patients with ARVC (http://arvcdatabase.info/), but recent evidence supports that they can also cause DCM (Pugh 2014). In summary, although additio nal studies are required to fully establish its clinical significance, the p.Gln 625X variant is likely pathogenic. -
Cardiovascular phenotype Pathogenic:1
The p.Q625* pathogenic mutation (also known as c.1873C>T), located in coding exon 14 of the DSP gene, results from a C to T substitution at nucleotide position 1873. This changes the amino acid from a glutamine to a stop codon within coding exon 14. This variant has been reported in arrhythmogenic right ventricular cardiomyopathy (ARVC) cohorts (Quarta G et al. Circulation, 2011 Jun;123:2701-9; Castelletti S et al. Int. J. Cardiol., 2017 Dec;249:268-273). Alterations in DSP that result in haploinsufficiency or protein truncation have been reported in patients with ARVC and dilated cardiomyopathy (DCM) (Fressart V et al. Europace. 2010;12(6):861-8; Elliott P et al. Circ Cardiovasc Genet. 2010;3(4):314-22; Quarta G et al. Circulation. 2011;123(23):2701-9; Garcia-Pavia P et al. Heart. 2011;97(21):1744-52; Rasmussen TB et al. Clin Genet. 2013;84(1):20-30; Pugh TJ et al. Genet Med. 2014;16(8):601-8). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at